Naveen Modi, Gerald Flattmann, and Rick Kirkbride have each been named Law360
2015 MVP award winners. Naveen Modi and Gerald Flattmann were recognized as IP MVPs
for their wins in two inter partes reviews
(“IPR”) related to biotechnology company Acorda Therapeutics, Inc.’s flagship drug Ampyra — a treatment that helps improve walking in people with Multiple Sclerosis. Law360
also noted Mr. Flattmann’s Patent Trial and Appeal Board (“PTAB”) win for Galderma Laboratories
—in the first-ever successful defense of a pharmaceutical patent in an IPR—and Mr. Modi’s PTAB win for Merck involving the pharmaceutical company's patent for Emend, an anti-nausea drug used during chemotherapy.
Rick Kirkbride was recognized as a Hospitality MVP
for his representation of Carey Watermark in nearly $1 billion in hotel acquisitions, Korean Air Lines in its $1 billion purchase of the Intercontinental Hotel and an office tower in downtown Los Angeles, and the $805 million sale of New York’s iconic Palace Hotel
to Hotel Lotte. Law360
reviewed more than 850 submissions for their MVP awards, selecting attorneys with “successes in high-stakes litigation, record-breaking deals and complex global matters” as this year’s MVPs. At Paul Hastings, our purpose is clear — to help our clients and people navigate new paths to growth. With a strong presence throughout Asia, Europe, Latin America, and the U.S., Paul Hastings is recognized as one of the world’s most innovative global law firms.